| |
| |
|
| Insider
Information: |
Sinha Vikas |
| Relationship: |
|
| City: |
Cheshire |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,308,459 |
|
|
Indirect Shares
|
16,674,766 |
|
|
| Direct
Value |
$33,429,650 |
|
|
|
Indirect Value
|
$12,692,832 |
|
|
| Total
Shares |
17,983,225 |
|
|
| Total
Value |
$46,122,482 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
23
|
|
Stock
price went up :
|
0
|
6
|
| Stock
price went down : |
0
|
17
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -743.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alexion Pharmaceuticals Inc |
ALXN |
EVP & CFO |
2016-08-08 |
178,463 |
2005-09-21 |
0 |
Premium* |
|
|
Allovir Inc |
ALVR |
|
2024-05-17 |
1,129,996 |
2024-05-17 |
16,674,766 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALXN |
Alexion Pharmaceuticals I... |
SVP & Chief Financial Officer |
• – – |
2008-01-10 |
4 |
S |
$69.02 |
$49,073 |
D/D |
(711) |
32,333 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & Chief Financial Officer |
• – – |
2008-03-24 |
4 |
S |
$58.21 |
$59,681 |
D/D |
(1,025) |
31,308 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2008-07-10 |
4 |
S |
$75.75 |
$12,044 |
D/D |
(159) |
31,149 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Sr. VP & CFO |
• – – |
2008-09-22 |
4 |
S |
$41.37 |
$85,429 |
D/D |
(2,065) |
60,233 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Sr. VP & CFO |
• – – |
2009-01-12 |
4 |
S |
$34.48 |
$12,930 |
D/D |
(375) |
59,858 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Sr. VP & CFO |
• – – |
2009-01-16 |
4 |
S |
$36.84 |
$61,191 |
D/D |
(1,661) |
58,197 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Sr. VP & CFO |
• – – |
2009-03-16 |
4 |
S |
$34.25 |
$80,727 |
D/D |
(2,357) |
63,840 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Sr. VP & CFO |
• – – |
2009-03-23 |
4 |
S |
$37.65 |
$59,675 |
D/D |
(1,585) |
62,255 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2009-07-10 |
4 |
S |
$36.93 |
$11,744 |
D/D |
(318) |
61,937 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2009-07-16 |
4 |
S |
$38.96 |
$15,467 |
D/D |
(397) |
61,540 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2009-09-22 |
4 |
S |
$46.27 |
$84,813 |
D/D |
(1,833) |
59,707 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2009-12-10 |
4 |
S |
$46.00 |
$460,000 |
D/D |
(10,000) |
49,707 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2010-01-11 |
4 |
S |
$47.68 |
$136,412 |
D/D |
(2,861) |
46,846 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2010-01-19 |
4 |
S |
$47.22 |
$25,452 |
D/D |
(539) |
46,307 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2010-07-12 |
4 |
S |
$51.91 |
$25,228 |
D/D |
(486) |
53,821 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CFO |
• – – |
2010-07-16 |
4 |
S |
$51.08 |
$27,583 |
D/D |
(540) |
53,281 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2011-01-10 |
4 |
S |
$81.27 |
$43,236 |
D/D |
(532) |
76,749 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2011-01-18 |
4 |
S |
$82.66 |
$44,636 |
D/D |
(540) |
76,209 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2011-01-27 |
4 |
S |
$84.70 |
$146,616 |
D/D |
(1,731) |
74,478 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2011-02-14 |
4 |
S |
$90.00 |
$1,800,000 |
D/D |
(20,000) |
86,480 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2011-07-11 |
4 |
S |
$50.00 |
$48,850 |
D/D |
(977) |
352,974 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2012-07-27 |
4 |
S |
$106.14 |
$3,361,363 |
D/D |
(30,868) |
314,520 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2012-07-31 |
4 |
S |
$104.94 |
$94,446 |
D/D |
(900) |
313,620 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2013-01-28 |
4 |
S |
$94.50 |
$95,162 |
D/D |
(1,007) |
312,613 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2013-01-29 |
4 |
S |
$94.32 |
$91,962 |
D/D |
(975) |
311,638 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
